| |
- Global and Regional Registration Strategy
- Expedited Market Entry for Novel Medicines
- Assessment of Regulatory Data Exclusivity
- Requirements for novel medicines, generics, bio-similar, well established products,fixed dose combinations
- Regional and National Application Requirements
- Procedures, Fees and Timelines
- Pre-submission Agency Consultations
- Dossier Development and CTD Conversion
- Regulatory Project Management
|
